期刊文献+

Hippo signaling:bridging the gap between cancer and neurodegenerative disorders 被引量:1

下载PDF
导出
摘要 During development,regulation of organ size requires a balance between cell proliferation,growth and cell death.Dysregulation of these fundamental processes can cause a variety of diseases.Excessive cell proliferation results in cancer whereas excessive cell death results in neurodegenerative disorders.Many signaling pathways known-to-date have a role in growth regulation.Among them,evolutionarily conserved Hippo signaling pathway is unique as it controls both cell proliferation and cell death by a variety of mechanisms during organ sculpture and development.Neurodegeneration,a complex process of progressive death of neuronal population,results in fatal disorders with no available cure to date.During normal development,cell death is required for sculpting of an organ.However,aberrant cell death in neuronal cell population can result in neurodegenerative disorders.Hippo pathway has gathered major attention for its role in growth regulation and cancer,however,other functions like its role in neurodegeneration are also emerging rapidly.This review highlights the role of Hippo signaling in cell death and neurodegenerative diseases and provide the information on the chemical inhibitors employed to block Hippo pathway.Understanding Hippo mediated cell death mechanisms will aid in development of reliable and effective therapeutic strategies in future.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2021年第4期643-652,共10页 中国神经再生研究(英文版)
基金 The authors are supported by the University of Dayton Graduate program of Biology This work was supported by NIH1R15GM124654-01 from the National Institutes of Health,Schuellein Chair Endowment Fund,and start-up support from the University of Dayton(to Amit S).
  • 相关文献

参考文献4

二级参考文献36

  • 1Aguzzi A, O'Connor T (2010) Protein aggregation diseases: pathogenic- ity and therapeutic perspectives. Nat Rev Drug Discov 9:237-248.
  • 2Bier E (2005) Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet 6:9-23.
  • 3Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Develop- ment 118:401-415.
  • 4Cao W, Song HI, Gangi T, Kelkar A, Antani I, Garza D, Konsolaki M (2008) Identification of novel genes that modify phenotypes induced by Alzheimer's beta-amyloid overexpression in Drosophila. Genetics 178:1457-1471.
  • 5Cauchi RJ, van den Heuvel M (2006) The fly as a model for neurodegen- erative diseases: is it worth the jump? Neurodegener Dis 3:338-356.
  • 6Cutler T, Sarkar A, Moran M, Steffensmeier A, Pull OR, Mancini G, Tare M, Gogia N, Singh A (2015) Drosophila eye model to study neuroprotective role of CREB binding protein (CBP) in Alzheimer's disease. PLoS One 10:e0137691.
  • 7Fernandez-Funez P, Sanchez-Garcia J, Ribncon-Limas DE (2013) Un- raveling the basis of neurodegeneration using the developing eye. New York: Springer.
  • 8Hardy J (2009) The amyloid hypothesis for Alzheimer's disease: a criti- cal reappraisal. J Neurochem 110:1129-1134.
  • 9Harvey BK, Richie CT, Hoffer BJ, Airavaara M (2011) Transgenic ani- mal models of neurodegeneration based on human genetic studies. J Neural Transm 118:27-45.
  • 10Iijima K, Iijima-Ando K (2008) Drosophila models of Alzheimer's amyloidosis: the challenge of dissecting the complex mechanisms of toxicity of amyloid-beta 42. J Alzheimers Dis 15:523-540.

共引文献22

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部